Endodiag

Founded in 2011, Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis, a complex and poorly known disease, affecting yet 10% of women of reproductive age (over 180 million patients worldwide!). Located in Evry, France, within Genopole, the French largest Biocluster, the company leverages the experience of its scientific cofounders who have been working in this field for over 20 years and a network of major hospital centres both in France and abroad. Although endometriosis is a major cause of subfertility (40% of affected patients are infertile) and chronic pain, it takes an average 8 to 10 years between the onset of the disease and its diagnosis, currently only achieved through surgery.